Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

31.72 +0.39 (+1.24%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 11, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,960,511
Open	31.27
Bid (Size)	31.61 (300)
Ask (Size)	31.72 (200)
Prev. Close	31.33
Today's Range	31.00 - 32.67
52wk Range	22.96 - 43.15
Shares Outstanding	99,581,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months ↗

May 04, 2026

The Street is bullish on this biotech's prospects, but is the sentiment justified?

Via The Motley Fool

Eli Lilly Just Announced Fantastic News for Shareholders ↗

May 04, 2026

Lilly's weight loss drugs have been delivering blockbuster revenue.

Via The Motley Fool

Performance

YTD	-10.4%	-10.4%
1 Month	-7.4%	-7.4%
3 Month	+8.3%	+8.3%
6 Month	-16.0%	-16.0%
1 Year	+12.1%	+12.1%

More News

Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge ↗

May 01, 2026

Via MarketBeat

Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead? ↗

April 30, 2026

Via The Motley Fool

Viking Therapeutics (NASDAQ:VKTX) Stock Holds Steady After Q1 2026 Earnings Miss on Higher Phase 3 Spending ↗

April 29, 2026

Via Chartmill

This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street ↗

April 26, 2026

Via The Motley Fool

Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom? ↗

April 25, 2026

Via The Motley Fool

The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

April 23, 2026

From Equity Insider

Via GlobeNewswire

Better Long-Term Buy: Eli Lilly or Viking Therapeutics? ↗

April 17, 2026

Via The Motley Fool

Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026? ↗

April 17, 2026

Via The Motley Fool

Better Healthcare Stock to Own in a Recession: Defensive or Growth? ↗

April 04, 2026

Via The Motley Fool

Where Will Viking Therapeutics Stock Be in 10 Years? ↗

April 03, 2026

Via The Motley Fool

The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets

April 03, 2026

Via MarketMinute

Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring

April 02, 2026

Via MarketMinute

2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More ↗

March 31, 2026

Via The Motley Fool

1 Reason This Biotech Stock Could Triple Before Year-End ↗

March 29, 2026

Via The Motley Fool

Why Viking Therapeutics Stock Could Take Off Later This Year ↗

March 23, 2026

Via The Motley Fool

Goldman Sachs Bullish Forecast: 15% Increase in 2026 U.S. M&A Activity

March 23, 2026

Via MarketMinute

Small-Cap Resilience: Russell 2000 Surges 3% as Geopolitical Tensions Ease and ‘Risk-On’ Appetite Returns

March 23, 2026

Via MarketMinute

Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics? ↗

March 22, 2026

Via The Motley Fool

Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics ↗

March 17, 2026

Via The Motley Fool

What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗

March 16, 2026

Via The Motley Fool

3 Companies at the Forefront of the GLP-1 Pill Wars ↗

March 16, 2026

Via MarketBeat

Here's Why Viking Therapeutics Stock Recovered and Can Soar 2026 ↗

March 11, 2026

Via The Motley Fool

VKTX Stock Extends Red-Hot Streak: Insider Scoops Up Shares As Multiple Phase 3 Trials Loom This Year In Obesity Race ↗

March 11, 2026

Via Stocktwits

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?

Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Viking Therapeutics, Inc. - Common Stock trade on?

Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?

The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market

What is the current price of Viking Therapeutics, Inc. - Common Stock?

The current price of Viking Therapeutics, Inc. - Common Stock is 31.72

When was Viking Therapeutics, Inc. - Common Stock last traded?

The last trade of Viking Therapeutics, Inc. - Common Stock was at 05/11/26 04:00 PM ET

What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?

The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.16B

How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?

Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.